A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Clinical trial NCT01682616 · COMPLETED
Trial details
- NCT number
- NCT01682616
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-25
- Primary completion
- 2022-06-23
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.